#AGENT_ROUTE	#TRIAL_ENROLL_DATE	#EVENT_TYPE	#DOSE_FREQUENCY	#TREATMENT_TYPE	#AGENT	#SITE	#SUBTYPE	#BEGINNING_DATE_OF_TREATMENT	#MEDICAL_REASON	#DATE	#DOSE	#Patient Identifier	#DOSE_UNIT	#END_DATE_OF_TREATMENT	
#AGENT_ROUTE	#TRIAL_ENROLL_DATE	#EVENT_TYPE	#DOSE_FREQUENCY	#TREATMENT_TYPE	#AGENT	#SITE	#SUBTYPE	#BEGINNING_DATE_OF_TREATMENT	#MEDICAL_REASON	#DATE	#DOSE	#Patient Identifier	#DOSE_UNIT	#END_DATE_OF_TREATMENT	

1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	
AGENT_ROUTE	TRIAL_ENROLL_DATE	EVENT_TYPE	DOSE_FREQUENCY	TREATMENT_TYPE	AGENT	SITE	SUBTYPE	BEGINNING_DATE_OF_TREATMENT	MEDICAL_REASON	DATE	DOSE	PATIENT_ID	DOSE_UNIT	END_DATE_OF_TREATMENT	
NA	2017/12/05	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	307	NA	2017/02/01	0.0	CMP-01-01	mg	757	
NA	2018/01/24	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	195	NA	2017/07/13	0.0	CMP-01-02	mg	595	
NA	2018/01/25	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	147	NA	2017/08/31	0.0	CMP-01-03	mg	546	
By mouth (PO)	2018/01/31	TREATMENT	Once Daily	MEDICAL THERAPY	SYNTHROID	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	232	HYPOTHYROIDISM	2017/06/13	0.025	CMP-01-04	mg	625	
NA	2018/01/31	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	232	NA	2017/06/13	0.0	CMP-01-04	mg	625	
By mouth (PO)	2018/02/08	TREATMENT	Every Morning	MEDICAL THERAPY	AMLODIPINE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	HYPERTENSION	2017/09/14	5.0	CMP-01-05	mg	532	
By mouth (PO)	2018/02/08	TREATMENT	Once Daily	MEDICAL THERAPY	HYDROCHLORTHIAZIDE (AVALIDE)	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	HYPERTENSION	2017/09/14	25.0	CMP-01-05	mg	532	
By mouth (PO)	2018/02/08	TREATMENT	Once Daily	MEDICAL THERAPY	IRBESARTAN (AVALIDE)	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	HYPERTENSION	2017/09/14	300.0	CMP-01-05	mg	532	
By mouth (PO)	2018/02/08	TREATMENT	Every Morning	MEDICAL THERAPY	MULTIVITAMIN AND MINERAL	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	WELLNESS	2017/09/14	1.0	CMP-01-05	TABLET	532	
By mouth (PO)	2018/02/08	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	PERCOCET	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	BILATERAL HIP AND KNEE PAIN, FIBROMYALGIA	2017/09/14	1.0	CMP-01-05	TABLET	532	
By mouth (PO)	2018/02/08	TREATMENT	Every Morning	MEDICAL THERAPY	RIVAROXABAN	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	147	DEEP VEIN THROMBOSIS	2017/09/14	20.0	CMP-01-05	mg	532	
NA	2018/02/08	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	147	NA	2017/09/14	0.0	CMP-01-05	mg	532	
By mouth (PO)	2018/02/21	TREATMENT	Every Morning	MEDICAL THERAPY	CANDESARTAN CILEXETIL	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	156	HYPERTENSION	2017/09/18	16.0	CMP-01-06	mg	528	
By mouth (PO)	2018/02/21	TREATMENT	Three Times Daily	MEDICAL THERAPY	FERROUS GLUCONATE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	156	ANEMIA	2017/09/18	35.0	CMP-01-06	mg	528	
By mouth (PO)	2018/02/21	TREATMENT	Every Morning	MEDICAL THERAPY	MULTIVITAMINS AND MINERALS	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	156	N/A	2017/09/18	1.0	CMP-01-06	TABLET	528	
By mouth (PO)	2018/02/21	TREATMENT	WEEKLY	MEDICAL THERAPY	RISEDRONATE SODIUM	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	156	OSTEOPOROSIS	2017/09/18	35.0	CMP-01-06	mg	528	
By mouth (PO)	2018/02/21	TREATMENT	Every Morning	MEDICAL THERAPY	ROSUVASTATIN	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	156	HYPERLIPIDEMIA	2017/09/18	10.0	CMP-01-06	mg	528	
NA	2018/02/21	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	156	NA	2017/09/18	0.0	CMP-01-06	mg	528	
By mouth (PO)	2018/08/09	TREATMENT	Once Daily	MEDICAL THERAPY	CANDESARTAN			Princess Margaret Cancer Centre	REGULAR MEDICATIONS	164	HYPERTENSION	2018/02/26	8.0	CMP-01-07	mg	367	
By mouth (PO)	2018/08/09	TREATMENT	Once Daily	MEDICAL THERAPY	HYDROCHLOROTHIAZIDE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	164	HYPERTENSION	2018/02/26	50.0	CMP-01-07	mg	367	
By mouth (PO)	2018/08/09	TREATMENT	Twice Daily	MEDICAL THERAPY	METOPROLOL	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	164	HYPERTENSION	2018/02/26	25.0	CMP-01-07	mg	367	
NA	2018/08/09	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	164	NA	2018/02/26	0.0	CMP-01-07	mg	367	
By mouth (PO)	2018/10/02	TREATMENT	Every Morning	MEDICAL THERAPY	AMLOPIDINE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	HYPERTENSION	2017/12/22	5.0	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	Every Morning	MEDICAL THERAPY	LEVOTHYROXINE SODIUM	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	HYPOTHYROIDISM	2017/12/22	0.1	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	LOPERAMIDE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	INCONTINENCE	2017/12/22	4.0	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	Every Night	MEDICAL THERAPY	MIRTAZAPINE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	MISCELLANEOUS ANTIDEPRESSANT	2017/12/22	45.0	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	Every Morning	MEDICAL THERAPY	PANTOPRAZOLE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	GASTROESOPHAGEAL REFLUX DISEASE	2017/12/22	40.0	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	Every Night	MEDICAL THERAPY	ROSUVASTATIN	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	DYSLIPIDEMIA	2017/12/22	40.0	CMP-01-08	mg	433	
By mouth (PO)	2018/10/02	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	SENOKOT	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	CONSTIPATION	2017/12/22	1.0	CMP-01-08	TAB	433	
Inhaler (IN)	2018/10/02	TREATMENT	Every Night	MEDICAL THERAPY	SPIRIVA	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	284	None	2017/12/22	18.0	CMP-01-08	ug	433	
NA	2018/10/02	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	284	NA	2017/12/22	0.0	CMP-01-08	mg	433	
By mouth (PO)	2018/11/13	TREATMENT	Every Morning	MEDICAL THERAPY	PERINDOPRIL ERBUMINE	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	1027	HYPERTENSION	2016/01/21	8.0	CMP-01-09	mg	1134	
By mouth (PO)	2018/11/13	TREATMENT	WEEKLY	MEDICAL THERAPY	RISEDRONATE SODIUM	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	1027	MISCELLANEOUS THERAPEUTIC AGENT	2016/01/21	35.0	CMP-01-09	mg	1134	
NA	2018/11/13	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	1027	NA	2016/01/21	0.0	CMP-01-09	mg	1134	
By mouth (PO)	2018/11/13	TREATMENT	Every Night	MEDICAL THERAPY	VITAMIN D	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	1027	SUPPLEMENT	2016/01/21	1000.0	CMP-01-09	IU	1134	
By mouth (PO)	2018/12/04	TREATMENT	Every Hour	MEDICAL THERAPY	CANNABIS OIL	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	299	INSOMNIA	2018/02/08	0.2	CMP-01-10	NA	385	
By mouth (PO)	2018/12/04	TREATMENT	Twice Daily	MEDICAL THERAPY	CLONAZEPAM	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	299	ANXIETY	2018/02/08	0.25	CMP-01-10	mg	385	
By mouth (PO)	2018/12/04	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	LORAZEPAM	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	299	ANXIETY	2018/02/08	1.0	CMP-01-10	mg	385	
NA	2018/12/04	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	Princess Margaret Cancer Centre	CLINICAL TRIALS	299	NA	2018/02/08	0.0	CMP-01-10	mg	385	
By mouth (PO)	2018/12/04	TREATMENT	Every Morning	MEDICAL THERAPY	VITAMIN B COMPLEX	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	299	SUPPLEMENT	2018/02/08	0.0	CMP-01-10	NA	385	
By mouth (PO)	2018/12/04	TREATMENT	Every Morning	MEDICAL THERAPY	VITAMIN D	Princess Margaret Cancer Centre	REGULAR MEDICATIONS	299	SUPPLEMENT	2018/02/08	0.0	CMP-01-10	NA	385	
IV	2018/06/15	TREATMENT	NA	MEDICAL THERAPY	BEVACIZUMAB	BCCA Vancouver Cancer Centre	Chemotherapy	445	Systemic chemotherapy for advanced/metastatic disease	2017/03/27	0.0	CMP-02-01	mg	703	
IV	2018/06/15	TREATMENT	NA	MEDICAL THERAPY	CAPECITABINE	BCCA Vancouver Cancer Centre	Chemotherapy	445	Adjuvant chemotherapy	2017/03/27	0.0	CMP-02-01	mg	703	
IV	2018/06/15	TREATMENT	NA	MEDICAL THERAPY	FLUOROURACIL	BCCA Vancouver Cancer Centre	Chemotherapy	445	Systemic chemotherapy for advanced/metastatic disease	2017/03/27	0.0	CMP-02-01	mg	703	
IV	2018/06/15	TREATMENT	NA	MEDICAL THERAPY	OXALIPLATIN	BCCA Vancouver Cancer Centre	Chemotherapy	445	Systemic chemotherapy for advanced/metastatic disease	2017/03/27	0.0	CMP-02-01	mg	703	
NA	2018/06/15	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	BCCA Vancouver Cancer Centre	CLINICAL TRIALS	445	NA	2017/03/27	0.0	CMP-02-01	mg	703	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	FLUOROURACIL	BCCA Vancouver Cancer Centre	Chemotherapy	267	Systemic chemotherapy for advanced/metastatic disease	2017/12/12	0.0	CMP-02-02	mg	443	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	LEUCOVORIN	BCCA Vancouver Cancer Centre	Chemotherapy	267	Systemic chemotherapy for advanced/metastatic disease	2017/12/12	0.0	CMP-02-02	mg	443	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	OXALIPLATIN	BCCA Vancouver Cancer Centre	Chemotherapy	267	Systemic chemotherapy for advanced/metastatic disease	2017/12/12	0.0	CMP-02-02	mg	443	
NA	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	BCCA Vancouver Cancer Centre	CLINICAL TRIALS	267	NA	2017/12/12	0.0	CMP-02-02	mg	443	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	BEVACIZUMAB	BCCA Vancouver Cancer Centre	Chemotherapy	274	Systemic chemotherapy for advanced/metastatic disease	2017/12/05	0.0	CMP-02-03	mg	450	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	FLUOROURACIL	BCCA Vancouver Cancer Centre	Chemotherapy	274	Systemic chemotherapy for advanced/metastatic disease	2017/12/05	0.0	CMP-02-03	mg	450	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	IRINOTECAN	BCCA Vancouver Cancer Centre	Chemotherapy	274	Systemic chemotherapy for advanced/metastatic disease	2017/12/05	0.0	CMP-02-03	mg	450	
IV	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	LEUCOVORIN	BCCA Vancouver Cancer Centre	Chemotherapy	274	Systemic chemotherapy for advanced/metastatic disease	2017/12/05	0.0	CMP-02-03	mg	450	
NA	2018/09/05	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	BCCA Vancouver Cancer Centre	CLINICAL TRIALS	274	NA	2017/12/05	0.0	CMP-02-03	mg	450	
By mouth (PO)	2018/10/25	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	ACETAMINOPHEN	BCCA Vancouver Cancer Centre	Chemotherapy	134	PAIN	2018/06/13	325.0	CMP-02-04	mg	260	
By mouth (PO)	2018/10/25	TREATMENT	Once Daily	MEDICAL THERAPY	FERROUS FUMARATE	BCCA Vancouver Cancer Centre	Chemotherapy	134	LOW IRON	2018/06/13	300.0	CMP-02-04	mg	260	
By mouth (PO)	2018/10/25	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	NAPROXEN	BCCA Vancouver Cancer Centre	Chemotherapy	134	SHOULDER PAIN	2018/06/13	220.0	CMP-02-04	mg	260	
By mouth (PO)	2018/10/25	TREATMENT	Once Daily	MEDICAL THERAPY	PANTOPRAZOLE	BCCA Vancouver Cancer Centre	Chemotherapy	134	ACID REFLUX	2018/06/13	40.0	CMP-02-04	mg	260	
NA	2018/10/25	TREATMENT	NA	MEDICAL THERAPY	TRIAL1	BCCA Vancouver Cancer Centre	CLINICAL TRIALS	134	NA	2018/06/13	0.0	CMP-02-04	mg	260	
By mouth (PO)	2018/10/25	TREATMENT	As Needed (PRN)	MEDICAL THERAPY	ZOPICLONE	BCCA Vancouver Cancer Centre	Chemotherapy	134	INSOMNIA	2018/06/13	7.5	CMP-02-04	mg	260	
